Science 37

02/04/2026

We are thrilled to welcome Kelly McKee to the Science 37 leadership team!
As our new 𝗩𝗶𝗰𝗲 𝗣𝗿𝗲𝘀𝗶𝗱𝗲𝗻𝘁 𝗼𝗳 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝘆 & 𝗧𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻, Kelly will lead the design of our future-state patient experience—driving growth through modernized trial ex*****on, advancing innovation, and strengthening cross-organizational collaboration to support long-term growth.

https://www.science37.com/science-37-appoints-kelly-johnston-mckee-as-vp-of-strategy-transformation/

02/02/2026

𝗦𝗵𝗲𝗹𝗹𝘆 𝗶𝘀 𝗯𝗮𝗰𝗸 🐢 𝗮𝘁 𝗦𝗖𝗢𝗣𝗘!

Stop by Booth #301 to support local children’s hospitals advancing clinical research.

𝗛𝗼𝘄 𝗶𝘁 𝘄𝗼𝗿𝗸𝘀:
• Visit Booth #301
• Choose a charity — we’ll donate on your behalf
• Take home a mini Shelly the Sea Turtle

Your support helps make a meaningful impact — both inside and outside clinical trials.

Plus: Watch our live at-home demos in action to see how we’re bringing trials directly to patients. 🏠

https://lnkd.in/eZm-jXKN

01/28/2026

CASE STUDY: Primary Biliary Cholangitis (PBC)
Enrolling 47% of Total U.S. Participants for a Phase 3 Hepatology Trial
Science 37 was the top enrolling site, contributing 47% of total U.S. study participants. Despite joining the trial 6 months later, enrollment was 11x faster compared to the other 141 participating traditional brick-and-mortar sites. Science 37 also achieved an 82% retention rate in patients transferred from traditional sites who were at risk of dropping out.

View the Case Study :https://www.science37.com/wp-content/uploads/2025/07/Science_37_Case_Studies_PBC-1.pdf

01/26/2026

Clinical trials are evolving, and regulators are taking notice. As research continues to move beyond traditional sites, decentralized trial elements are becoming a key part of making studies more accessible, efficient, and patient-centric.

🔬 Learn why the FDA’s recognition of decentralized trial elements matters and what it means for the future of clinical research in this latest blog from Science 37:
👉 Read the full article here:

In its Final Guidance on Decentralized Clinical Trials, the FDA provides recommendations for trial sponsors […]

01/22/2026

Attend Our Live At-Home Demos at SCOPE 2026
February 3-4
Rosen Shingle Creek, Orlando, FL
Booth #301
Step into our living room at Booth #301 and experience how we deliver clinical trials to participants’ homes through interactive demos led by our expert board-certified Investigator and Research-Grade Nurses.
Reserve Your Spot Today!

Scope Summit 2026 | Science 37 https://www.science37.com/scope-summit-2026/

01/21/2026

For most families, hunger is a natural part of daily life - a signal that comes and goes. But for people living with Prader-Willi Syndrome (PWS), that signal doesn’t function in the same way. Hunger can feel persistent and difficult to manage, creating challenges that touch nearly every part of daily life. Clinical research is […]

Read now: How Clinical Research is Transforming Life with Prader-Willi Syndrome - Science 37 Studies https://studies.science37.com/how-clinical-research-is-transforming-life-with-prader-willi-syndrome/?&

01/19/2026

Caring for someone with Dravet Syndrome can be overwhelming and full of questions. Our latest guide breaks down what this rare form of epilepsy is, practical tips for caregivers, and how research — including Science 37 studies — is helping shape better support and understanding.

👉 Read the full blog now.
Stay informed, feel empowered, and connect with a community that cares.
https://studies.science37.com/navigating-dravet-syndrome-a-guide-for-caregivers-on-rare-epilepsy/

For most people, epilepsy is a condition characterized by occasional seizures that, with the right medication, can often be managed. But for the parents of a child with Dravet Syndrome, the reality is vastly different. Dravet Syndrome is not just "epilepsy." It is a rare, catastrophic form of geneti...

01/16/2026

Science 37 Named Finalist in Two Categories for the 2026 SCOPE Awards | Science 37
https://www.science37.com/science-37-named-finalist-in-two-categories-for-the-2026-scope-awards/

01/14/2026

January is here, and with it comes the annual tidal wave of "New Year, New Me" messaging. Gym memberships skyrocket, grocery stores push kale smoothies to the front of the aisle, and millions of people set out with the best intentions to overhaul their health. But for the millions of Americans living with obesity, this […]

Read now: Beyond Willpower: The Science of Obesity & New Paths to Management - Science 37 Studies https://studies.science37.com/beyond-willpower-the-science-of-obesity-new-paths-to-management/?&

01/12/2026

We won the Research and Development award in the Site Innovation category in the 2025 Clinical Trials Arena Excellence Awards for its transformative approach to clinical trial conduct.
Science 37 Honored for Site Innovation in the 2025 Clinical Trials Arena Excellence Awards

Science 37 is the Winner of Research and Development Award in the Site Innovation category in the 2025 Clinical Trials Arena Excellence Awards

01/08/2026

Access 100% of your target population with the industry's only FDA-Inspected Direct-to-Patient Site
By bringing clinical research to the patients’ home with high quality care, and the detailed ex*****on, delivery, and data collection you expect from your best sites.

Science 37’s Direct-to-Patient Site enables sponsors to reach 100% of their target patient population by conducting study visits in patients’ homes. With 50-state licensure, our medical teams manage studies nationwide, ensuring broad patient access. This nationwide capability facilitates seamless enrollment regardless of the participant’s location.

01/06/2026

Virtual sites can help deliver infectious disease studies more quickly, more inclusively and in a more patient-centric way.
To explore more ways that sponsors of infectious disease studies can benefit from using virtual approaches such as the Science 37 Metasite, read our playbook.

Top Five Reasons to Include Virtual Sites in Your Infectious Disease Research | Science 37

Author: Debra Weinstein, MD, Vice President - Internal Medicine Virtual sites can help deliver infectious […]